Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.12% | 7.60% | 31.62% | 12.02% | -13.62% |
| Total Depreciation and Amortization | -2.46% | 2.79% | 55.54% | 25.42% | -3.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.34% | -42.48% | -36.69% | -21.99% | 52.43% |
| Change in Net Operating Assets | 3,765.66% | 680.51% | 32.63% | 17.92% | -95.82% |
| Cash from Operations | 355.07% | 786.43% | 124.41% | 19.99% | -449.46% |
| Capital Expenditure | -76.63% | 4.65% | 58.26% | 70.25% | 43.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -39,968.69% | -205,058.26% | -- |
| Cash from Investing | -11,988.19% | -6,446.16% | -5,209.32% | -5,586.41% | 43.53% |
| Total Debt Issued | -100.00% | -- | 705.00% | 705.00% | 705.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.41% | -80.20% | -59.78% | -83.88% | -73.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.88% | -- | -662.82% | -1,904.16% | -5,302.47% |
| Cash from Financing | -111.69% | 901.23% | 1,074.60% | 153.94% | 182.96% |
| Foreign Exchange rate Adjustments | 42.79% | -120.60% | 147.93% | 107.68% | 150.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -185.89% | -67.36% | 1,183.38% | -48.96% | 213.56% |